Impact of Acetazolamide and CPAP on Cortical Activity in Obstructive Sleep Apnea Patients

• Katrin Stadelmann,

  Affiliations Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland, Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland

  ⨯
• Tsogyal D. Latshang,

  Affiliation Pulmonary Division, University Hospital Zurich, Zurich, Switzerland

  ⨯
• Yvonne Nussbaumer-Ochsner,

  Affiliation Pulmonary Division, University Hospital Zurich, Zurich, Switzerland

  ⨯
• Leila Tarokh,

  Affiliations Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland, University Hospital of Child and Adolescent Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland

  ⨯
• Silvia Ulrich,

  Affiliation Pulmonary Division, University Hospital Zurich, Zurich, Switzerland

  ⨯
• Malcolm Kohler,

  Affiliations Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland, Pulmonary Division, University Hospital Zurich, Zurich, Switzerland

  ⨯
• Konrad E. Bloch,

  Affiliations Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland, Pulmonary Division, University Hospital Zurich, Zurich, Switzerland

  ⨯
• Peter Achermann

  * E-mail: acherman@pharma.uzh.ch

  Affiliations Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland, Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland

  ⨯